SCHEMBL1037124

SCHEMBL1037124

Cc1noc(NC(=O)N2CCC(=Cc3cccc(OCCc4ccccc4)c3)C(C)C2)c1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 1/20 0.38
PTPN1 P18031 5/20 0.38
AKR1B1 P15121 3/20 0.38
GPR55 Q9Y2T6 2/20 0.38
FAAH O00519 4/20 0.36
PTPN2 P17706 2/20 0.36
ACP1 P24666 2/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
MAPK1 P28482 1/20 0.35
HSD17B10 Q99714 1/20 0.35
GPR18 Q14330 1/20 0.34
USP2 O75604 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
POLB P06746 1/20 0.34
TSHR P16473 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
PPARG P37231 2/20 0.33
PPARA Q07869 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1037122 1.00 ENPP2 (0.38) ENPP2PTPN1AKR1B1GPR55FAAH
SCHEMBL1037384 0.94 F10 (0.38) ENPP2PTPN1MEN1KMT2AMAPK1
SCHEMBL1037380 0.94 F10 (0.38) ENPP2PTPN1MEN1KMT2AMAPK1
SCHEMBL1033980 0.94 OGA (0.37) ENPP2FAAHMEN1KMT2AMAPK1
SCHEMBL1033981 0.94 OGA (0.37) ENPP2FAAHMEN1KMT2AMAPK1
SCHEMBL1037027 0.93 F10 (0.39) ENPP2PTPN1AKR1B1GPR55FAAH
SCHEMBL1037028 0.93 F10 (0.39) ENPP2PTPN1AKR1B1GPR55FAAH
SCHEMBL1036425 0.92 CYP3A4 (0.37) ENPP2FAAHMEN1KMT2AMAPK1
SCHEMBL1036427 0.92 CYP3A4 (0.37) ENPP2FAAHMEN1KMT2AMAPK1
SCHEMBL1036592 0.91 OGA (0.33) ENPP2PTPN1AKR1B1GPR55FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110053982-A1 ETHER BENZYLIDENE PIPERIDINE 5-MEMBERED ARYL CARBOXAMIDE COMPOUNDS USEFUL AS FAAH INHIBITORS PFIZER INC. (US) 2011-03-03 US claimed
EP-2276738-A1 ETHER BENZYLIDENE PIPERIDINE 5-MEMBERED ARYL CARBOXAMIDE COMPOUNDS USEFUL AS FAAH INHIBITORS Pfizer Inc. (US) 2011-01-26 EP claimed
WO-2009127943-A1 ETHER BENZYLIDENE PIPERIDINE 5-MEMBERED ARYL CARBOXAMIDE COMPOUNDS USEFUL AS FAAH INHIBITORS PFIZER INC. (US) 2009-10-22 WO claimed
US-20110053982-A1 ETHER BENZYLIDENE PIPERIDINE 5-MEMBERED ARYL CARBOXAMIDE COMPOUNDS USEFUL AS FAAH INHIBITORS PFIZER INC. (US) 2011-03-03 US disclosed
EP-2276738-A1 ETHER BENZYLIDENE PIPERIDINE 5-MEMBERED ARYL CARBOXAMIDE COMPOUNDS USEFUL AS FAAH INHIBITORS Pfizer Inc. (US) 2011-01-26 EP disclosed
WO-2009127943-A1 ETHER BENZYLIDENE PIPERIDINE 5-MEMBERED ARYL CARBOXAMIDE COMPOUNDS USEFUL AS FAAH INHIBITORS PFIZER INC. (US) 2009-10-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110053982-A1 ETHER BENZYLIDENE PIPERIDINE 5-MEMBERED ARYL CARBOXAMIDE COMPOUNDS USEFUL AS FAAH INHIBITORS FAAH, FAAH2, CNR2 ENPP2 59/4885PTPN1 3961/4885AKR1B1 581/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.